MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus)

Table 1 Subjects’ clinical and metabolic characteristics

	HC (n = 20)	Type 1 diabetes (n = 29)	p-value
Age (years)	46.5 ± 11.7	47.2 ± 12.7	0.8
BMI (kg/m²)	26.0 ± 4.5	28.4 ± 6.7	0.3
Gender (M/F) n	9/11	14/15	–
HbA1c (mmol/mol)	35.1 ± 2.8	57.3 ± 7.6	< 0.001***
HbA1c (%)	5.4 ± 0.3	7.4 ± 0.7	< 0.001***
Glucose (mmol/L)	4.8 ± 1.0	9.7 ± 3.7	< 0.001***
CD34⁺ CD133⁺ per 100 lymphocytes	0.09 ± 0.03	0.02 ± 0.01	< 0.001***
Fibronectin adhesion assay per hpf	68.6 ± 34.5	33.9 ± 14.7	0.01*

Body mass index (BMI), male (M), female (F), high power field (hpf). *p < 0.05, ** p < 0.01, ***p < 0.001

ISSN: 1479-5876